We found anti-MDA5 positive patients to have a 7.5 fold increased risk of ILD, however lack of details on the severity of ILD prevented us from studying the association with rapidly progressive disease, which is a limitation of our study. This evidence concerns the gene IFIH1 and interstitial lung disease.